Qing Song Health Co.,Ltd. (TPE:6931)
Taiwan · Delayed Price · Currency is TWD 50.00
0.00 (0.00%)
At close: Apr 24, 2026
Qing Song Health Market Cap
Qing Song Health has a market cap or net worth of 3.31 billion as of April 24, 2026. Its market cap has decreased by -28.98% in one year.
Market Cap
3.31B
Enterprise Value
3.70B
Revenue
1.12B
Ranking
n/a
PE Ratio
35.97
Stock Price
50.00
Market Cap Chart
Since December 27, 2022, Qing Song Health's market cap has increased from 2.32B to 3.31B, an increase of 42.60%. That is a compound annual growth rate of 11.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 3.31B | -20.51% |
| Dec 31, 2025 | 4.16B | -29.22% |
| Dec 31, 2024 | 5.88B | 28.33% |
| Dec 29, 2023 | 4.58B | 120.52% |
| Dec 30, 2022 | 2.08B | -10.44% |
| Dec 27, 2022 | 2.32B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 233.46B |
| Caliway Biopharmaceuticals | 170.42B |
| Heron Neutron Medical | 62.93B |
| Lotus Pharmaceutical | 58.74B |
| Merdury Biopharmaceutical | 3.45B |
| Genovate Biotechnology | 3.41B |
| Intech Biopharm | 3.39B |
| Shine-On BioMedical | 3.28B |